Yes, herpes can cause burning, and the sensation is a direct product of how the virus injures small sensory nerve endings in skin and mucosa. Burning is most characteristic of the prodrome, the 12-to-24-hour window before visible lesions appear, but it can persist through the blister phase and, in some people, linger for weeks after the skin has healed. The burning is neuropathic in origin, not a simple surface irritation, which explains why it can feel out of proportion to what is visible.
The nerve mechanism behind herpetic burning
Herpes simplex virus types 1 and 2 establish latency in the dorsal root ganglia and reactivate along the sensory axon back toward the skin. When the virus reactivates, it replicates in epithelial cells and simultaneously triggers inflammation in the fine unmyelinated C-fibers and thin myelinated A-delta fibers that carry pain and temperature signals. These fibers become sensitized.
The sensitization has a specific chemistry. Viral replication and the immune response release bradykinin, prostaglandins, and nerve growth factor, which lower the activation threshold of nociceptors. In plain terms, the nerve endings become trigger-happy and begin firing in response to stimuli that would normally be innocuous. Ectopic firing from these sensitized endings reaches the brain as burning, tingling, or electric shock, which is why clinicians describe the prodrome as neuropathic rather than inflammatory pain.
Burning is also why herpes pain often precedes any visible change. The virus is already active in the nerve and skin before vesicles form, so the symptom signature leads the physical exam. This has a practical consequence: burning alone, without lesions, is a legitimate reason to seek testing, but it is not diagnostic on its own.
How common burning is, and how long it lasts
Burning or tingling during the prodrome is reported by roughly half to two-thirds of people with recurrent genital herpes, according to clinical descriptions synthesized in major society guidance. The first episode tends to be more painful and longer than recurrences, and burning is more prominent in primary infection.
The time course is fairly consistent across recurrences. The table below reflects typical timing described in clinical literature; individual variation is wide and these are general patterns, not predictions for any one person.
| Phase | Typical timing | What the burning feels like |
|---|---|---|
| Prodrome | 12-24 hours before lesions | Tingling, burning, electric sensation in a localized patch |
| Vesicle formation | Hours to 1 day after prodrome | Burning intensifies, often with itching |
| Ulceration | Day 1-3 of lesions | Burning peaks, sometimes sharp or raw |
| Crusting | Day 3-7 | Burning fades, replaced by tenderness |
| Healing | Day 7-14 (primary may be longer) | Residual burning can persist after skin closes |
| Post-healing | Up to 1-4 weeks | Occasional burning without visible lesions in some people |
The post-healing phase matters because it is where people get confused. Burning without a visible lesion can be residual nerve sensitization, a new prodrome, or something else entirely. It is not automatically a sign the virus is actively shedding.
When burning is not herpes
Burning genital or oral pain has a long differential, and herpes is only one entry. Two comparisons are worth keeping straight.
| Condition | Burning pattern | Distinguishing feature |
|---|---|---|
| Herpes simplex | Localized, precedes lesions, recurs in same spot | Grouped vesicles on red base |
| Candidiasis | Diffuse burning with itching | White discharge, no vesicles |
| Bacterial vaginosis | Minimal burning, more odor | Thin gray discharge |
| Contact dermatitis | Burning after exposure | Rash follows contact, no vesicles |
| Urinary tract infection | Burning with urination | Frequency, urgency, no skin lesions |
| Shingles (herpes zoster) | Unilateral burning along a dermatome | Band-like distribution, older adults |
The pattern matters more than the sensation. Herpes burning is usually focal, recurs in roughly the same location, and is followed by vesicles within a day. Burning that is diffuse, follows a nerve band, or comes with discharge points elsewhere. A clinician can distinguish these with examination and, when needed, a swab of an active lesion for nucleic acid testing, which is more sensitive than culture and is the preferred method in current guidance (CDC).
The counterintuitive part: burning severity does not track lesion severity
A common assumption is that worse burning means worse outbreak. Clinical observation runs the other way. People with mild or barely visible recurrences sometimes report intense prodromal burning, while some first episodes with extensive ulceration are described as more raw than burning.
The reason is neurological. Burning intensity depends on how sensitized the local nerve endings are and how the central nervous system amplifies the signal, not on how much skin is involved. Prior episodes can leave a kind of nerve memory that makes subsequent prodromes feel more pronounced. This is a professional caveat worth stating plainly: symptom intensity is a poor proxy for viral activity, and it should not be used to judge contagiousness or treatment need.
Red flags that change the urgency
Most herpetic burning is manageable and self-limited. Some patterns warrant prompt evaluation. Treat these as bullets for screening, not as a diagnosis:
Burning with fever, headache, stiff neck, or confusion, especially in the first episode Burning near the eye, with redness, tearing, or light sensitivity Burning in a person who is pregnant, immunocompromised, or has known HIV Burning with inability to urinate or severe genital swelling Burning that spreads rapidly or comes with widespread blisters Burning in an infant or young child with lethargy or poor feeding
These patterns point toward complications or alternative diagnoses that need same-day clinical assessment. They are rare, but they are the reason burning should not always be self-managed.
Practical steps and thresholds for action
For most adults with recurrent, mild burning and a known herpes diagnosis, the practical actions are straightforward. The thresholds below are general decision points, not personalized treatment advice.
First, note timing. If burning reliably precedes lesions by 12-24 hours, that pattern is useful information to bring to a clinician, because it supports the diagnosis and can inform whether episodic antiviral treatment is appropriate. Episodic therapy works best when started within 1 day of prodrome onset, according to prescribing guidance for antivirals such as acyclovir, valacyclovir, and famciclovir (FDA labeling).
Second, test when there is something to test. A swab of an active vesicle or ulcer has the highest yield. A negative swab does not rule out herpes, particularly if taken after lesions have crusted. Blood antibody testing can support a diagnosis between episodes but cannot tell you whether a current burning sensation is an outbreak.
Third, treat symptoms conservatively while awaiting evaluation. Cool compresses, loose clothing, and over-the-counter analgesics are reasonable for mild burning. Avoid topical anesthetics without guidance, because some can irritate mucosa.
Fourth, know when to stop self-managing. Burning that lasts more than 2 weeks, recurs more than 6 times a year, or comes with the red flags above deserves clinical review. Frequent recurrences are one threshold at which suppressive antiviral therapy is typically discussed.
Fifth, budget realistically. Generic acyclovir is inexpensive, often under USD 30 for a course, while brand-name episodic antivirals cost more; prices vary widely by pharmacy and insurance. Cost should not be a reason to skip an evaluation, but it is worth asking about generic options.
What the evidence can and cannot tell you
The mechanism of herpetic burning is well established: nerve sensitization from viral replication and local inflammation. The epidemiology of prodromal symptoms is described in clinical series but is not precisely quantified in large population studies, so the "half to two-thirds" figure should be read as an approximate clinical impression rather than a measured statistic. Time-course tables reflect typical patterns, not guarantees.
What remains uncertain is why some people have prominent burning and others have none, and how much of post-healing burning reflects residual nerve sensitization versus subclinical reactivation. Current evidence supports the neuropathic explanation but does not give a clean threshold for when burning alone should trigger antiviral treatment. The honest position is that burning is a real, mechanistically grounded symptom of herpes, useful for pattern recognition and timing of care, but not a stand-alone diagnostic or severity marker.